Holen Sie sich die Stockscreener-App
0.4692
0.06%
0.0003
Schlusskurs vom Vortag:
$0.4689
Offen:
$0.451
24-Stunden-Volumen:
37,755
Relative Volume:
0.20
Marktkapitalisierung:
$41.64M
Einnahmen:
$8.90M
Nettoeinkommen (Verlust:
$-4.57M
KGV:
-8.4388
EPS:
-0.0556
Netto-Cashflow:
$-1.84M
1W Leistung:
-6.53%
1M Leistung:
+2.89%
6M Leistung:
+62.35%
1J Leistung:
-24.38%
1-Tages-Spanne:
$0.451
$0.47
1-Wochen-Bereich:
$0.45
$0.49
52-Wochen-Spanne:
$0.2181
$0.64
Milestone Scientific Inc. Stock (MLSS) Company Profile
Firmenname
Milestone Scientific Inc.
Sektor
Telefon
973-535-2717
Adresse
220 South Orange Avenue, Livingston, NJ
Compare MLSS vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MLSS
Milestone Scientific Inc.
|
0.4692 | 41.73M | 8.90M | -4.57M | -1.84M | -0.0556 |
ISRG
Intuitive Surgical Inc
|
366.70 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
184.74 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
70.50 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
228.35 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.59 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-09-16 | Eingeleitet | Northland Capital | Market Perform |
| 2018-11-16 | Bestätigt | Maxim Group | Buy |
| 2016-12-23 | Bestätigt | Maxim Group | Buy |
| 2015-12-11 | Eingeleitet | Maxim Group | Buy |
Milestone Scientific Inc. Aktie (MLSS) Neueste Nachrichten
Milestone Scientific Q2 revenue up 22%; affirms FY26 guidance - scanx.trade
Benchmark reiterates Speculative Buy on Milestone Scientific stock By Investing.com - Investing.com Australia
MLSS Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline Despite Revenue UncertaintyNon-GAAP Earnings - vinanet.vn
Benchmark reiterates Speculative Buy on Milestone Scientific stock - Investing.com
Transcript: Milestone Scientific Q2 2026 Earnings Conference Call - Sahm
Milestone Scientific’s Global Exposure: Geopolitical and China Risks Threaten Supply Chain and Revenue - TipRanks
Milestone Scientific Inc (MLSS) (Q2 2026) Earnings Call Highligh - GuruFocus
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Milestone Scientific Releases Q2 2026 Financial Results - AlphaStreet
Milestone Scientific Q3 Sales Guidance Misses $2.510M Estimate - scanx.trade
Earnings call transcript: Milestone Scientific posts Q2 2026 revenue growth By Investing.com - Investing.com India
MLSS: Q2 revenue up 22% year-over-year, medical segment surges, 2026 guidance reaffirmed - TradingView
Earnings call transcript: Milestone Scientific posts Q2 2026 revenue growth - Investing.com
Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Milestone Scientific Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Milestone Scientific Reports 231% Growth in Medical Revenue, Announces VA and DoD Distribution Agreement and Reaffirms 2026 Outlook - Quiver Quantitative
Milestone Scientific Reports Financial Results for Second Quarter 2026 - marketscreener.com
Press Release: Milestone Scientific Reports Financial Results for Second Quarter 2026 - Moomoo
Milestone Scientific Inc (MLSS) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on ... By GuruFocus - Investing.com Canada
Milestone Scientific (NYSE: MLSS) grows revenue 22% but flags going concern risk - Stock Titan
Milestone Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Earnings To Watch: Milestone Scientific Inc (MLSS) Q2 2026 -- GF Value Sees 13% Upside - Yahoo Finance
Milestone Scientific (MLSS) Advances 3.01% to $0.48, Approaching Key $0.50 ResistanceETF Premium Discount - vinanet.vn
Milestone Scientific to host Q2 earnings conference call - Bitget
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call - The Manila Times
Computerized drug-delivery developer sets Aug. 14 results call - Stock Titan
Milestone Scientific (MLSS) Inches Higher to $0.46 as Consolidation ContinuesProtective Put - vinanet.vn
Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System - The Manila Times
Epidural Device to Be Marketed Across VA and Military Systems - Stock Titan
Milestone Scientific signs federal distribution deal with Red One - scanx.trade
Milestone Scientific Inc. (NYSE: MLSS) investors back higher share and equity plan limits - Stock Titan
Milestone Scientific, Inc. Revenue Breakdown – AMEX:MLSS - TradingView
Milestone Scientific Directors Elect Conversion of Bridge Notes - TipRanks
Milestone Scientific (NYSE: MLSS) directors plan bridge note conversions - Stock Titan
Milestone Scientific Inc. (MLSS) Gains 3.13% as Stock Tests Key Resistance at $0.42ETF Inflow Streak - dars.gov.et
Milestone Scientific Inc (MLSS) Cash Flow - TradingKey
Milestone Scientific Inc (MLSS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TradingKey - TradingKey
Milestone Scientific Inc (MLSS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Milestone Scientific Inc (MLSS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Milestone Scientific Inc (MLSS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MLSS|Milestone Scientific Inc|Price:0.390|Chg%:-0.008 - TradingKey
MLSS|Milestone Scientific Inc|Price:0.414|Chg%:+0.024 - TradingKey
MLSS Q1 2026 Earnings: Improved Loss Per Share Beats Estimates, Stock Gains 4%Earnings Analysis - Vinanet
Milestone Scientific expects Q2 revenue of $2.8M - MSN
MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SentimentEarnings Turnaround - vinanet.vn
Milestone Scientific (MLSS) Shows Modest Gain, Tests Key Resistance at $0.45PCR Spike - Vinanet
Top Five Milestones in Space Exploration History - Encyclopedia Britannica
Milestone Scientific Launches First Phase of AI Strategy With Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026 - 富途牛牛
Milestone Scientific Launches First Phase of AI Strategy - GlobeNewswire
Milestone Scientific (MLSS) Gains 3.38% as Stock Tests Key Resistance LevelRunaway Gap - Vinanet
Finanzdaten der Milestone Scientific Inc.-Aktie (MLSS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Milestone Scientific Inc.-Aktie (MLSS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BP4 S.r.l. | 10% Owner |
Oct 23 '25 |
Sale |
0.43 |
80,000 |
34,416 |
8,996,765 |
| BP4 S.r.l. | 10% Owner |
Oct 22 '25 |
Sale |
0.45 |
14,427 |
6,488 |
9,076,765 |
| BP4 S.r.l. | 10% Owner |
Oct 21 '25 |
Sale |
0.44 |
40,000 |
17,592 |
9,091,192 |
| BP4 S.r.l. | 10% Owner |
Oct 20 '25 |
Sale |
0.45 |
24,034 |
10,880 |
9,131,192 |
| BP4 S.r.l. | 10% Owner |
Oct 14 '25 |
Sale |
0.54 |
30,000 |
16,185 |
9,155,226 |
| BP4 S.r.l. | 10% Owner |
Oct 10 '25 |
Sale |
0.55 |
10,158 |
5,588 |
9,185,226 |
| BP4 S.r.l. | 10% Owner |
Oct 13 '25 |
Sale |
0.55 |
10,000 |
5,500 |
9,175,226 |
| BP4 S.r.l. | 10% Owner |
Oct 08 '25 |
Sale |
0.47 |
30,000 |
13,950 |
9,195,384 |
| BP4 S.r.l. | 10% Owner |
Oct 07 '25 |
Sale |
0.45 |
10,000 |
4,500 |
9,225,384 |
| BP4 S.r.l. | 10% Owner |
Oct 03 '25 |
Sale |
0.45 |
19,210 |
8,636 |
9,235,384 |
0.76%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):